Get started
SELECT SECTOR SPDR TRUST HEALTHCARESELECT SECTOR SPDR TRUST HEALTHCARESELECT SECTOR SPDR TRUST HEALTHCARE

SELECT SECTOR SPDR TRUST HEALTHCARE

No trades
See on Supercharts
Overview Analysis Holdings News
Ideas
Discussions Technicals Seasonals

XLV trade ideas

Ascending TriangleGappy under price so beware. Gaps overhead cause R. Gaps underneath can provide support but can also fill )o: There is also several bearish rising wedges in the yearly chart but XLV has broken the bottom trendline of each to some degree Rising wedges are usually bearish and resembles a channel but both lines slope up and narrow at the apex A RW causes an issue with supply and demand due to lack of healthy pull backs. Can be a very long term pattern An ascending triangle is a chart pattern used in technical analysis. It is created by price moves that allow for a horizontal line to be drawn along the swing highs, and a rising trendline to be drawn along the swing lows. Ascending triangles are thought of as bullish, but in reality that can bust and break down as well Just an observation Top 10 Holdings Johnson & Johnson 9.45% UnitedHealth Group Inc 7.59% Pfizer Inc 5.16% Merck & Co Inc 4.98% Thermo Fisher Scientific Inc 4.90% Abbott Laboratories 4.87% AbbVie Inc 3.93% Danaher Corp 3.79% Medtronic PLC 3.54% Bristol-Myers Squibb Company
AMEX:XLVLong
by lauralea
Healthcare Critical LevelTechnical Analysis The 200ema has been tested several times, and has worked very well as a mid-term support level. Risk reward ratio is easy to set-up with a 3:1 ratio approximately. Sector & Industry Analysis It is important to note that the industries inside the sector have different performance, which has been very useful to analyze what the market thinks of the risk of healthcare with the election coming up. The following list is the Healthcare Industries with a 6-month performance % move, as well as a some good ETF to follow/trade: Healthcare Technology --> +56% // have not found appropriate ETF. Biotechnology --> +21% // XBI (smaller biotech), IBB (large-cap biotech), ARKG (genomics) Healthcare Equipment --> +19% // IHI Healthcare Providers --> +5.51% // IHF Pharmaceuticals --> -1.3% // IHE
AMEX:XLV
by dorfmanmaster
Health Care ETF Sneaks to New HighsThe SPDR Health Care ETF broke above its pre-Covid highs on July 17. Now it’s pulled back and is bouncing at those old levels. Is a stealth breakout taking place? XLV has also formed a bullish ascending triangle, which it’s broken to the upside. Health care is interesting because it lost more than 1 million workers amid the coronavirus lockdowns (according to Labor Department data). It’s not as bad as hotels or airlines, but it was clearly disrupted. However unlike hotels and airlines, health care is a non-cyclical part of the economy that can still work during a recession. And recent numbers show it might be rebounding quickly. For example hospital operator HCA is up 35 percent in the last month, partially because admittances are rebounding. Equipment providers like Intuitive Surgical and Abiomed have also jumped as procedures resume. Overall health-care isn’t the most exciting sector. But it is a big chunk of the economy. Like housing, it’s likely to recover much more quickly from the pandemic than other sectors. That may keep the buyers engaged, especially if XLV holds the recent low of $104.43.
AMEX:XLVLong
by TradeStation
XLV prepare to Long, double bottom Existing condition: 1. Weekly demand zone confirmed 2. 15 min Chart double bottom formed Buy 75.5 or better price Stop: 73.5 Target 1: 81.5; risk:reward=1:3 Target 2: 86; risk:reward=1:5 This is a trading school homework. I need 6 months to practice trading plan. If you like it, thank you for your support. Please use SIM/Demo account to try it, until my trading plans get high winning rate. Sum of my ideas: 1 winner, 1 loser, 4 active, 8 cancelled, 4 pending for condition, 1 analysis only.
AMEX:XLVLong
by PlanTradePlanMM
Healthcare probably going to take a hit this weekCongress's coronavirus stimulus deal reached Friday night included a provision requiring health insurers to bear the full cost of coronavirus test kits and to waive copays. The federal government will pay the cost for the uninsured. This will probably hurt health insurers Monday, though it might be good for service providers. Here's another piece of bad news: xenophobia related to the virus has angered the Chinese government, and China’s official newspaper Xinhua published a threat to cut off supply chains for the US pharmaceutical industry. If China followed through on this threat, there could be big US drug shortages, which would be bad for pharmaceutical and healthcare companies. The whole economy will be down this week due to expanding quarantines, new travel bans, and the failure of Trump's payroll tax cut proposal, but the healthcare sector may take extra damage Monday as it bears the brunt of the cost of coronavirus testing.
AMEX:XLVShort
by ChristopherCarrollSmith
4